How Often Does the FDA Disagree With Its Advisory Committees’ Recommendations?
According to the findings of a recent review, the Food and Drug Administration rarely disagrees with recommendations made by its advisory committees.
All articles by Cassandra Pardini, PharmD
Higher Intensity Therapy With Simvastatin-Ezetimibe May Benefit Elderly Patients After ACS
The updated AHA/ACC cholesterol management guidelines recommend moderate or high intensity statin therapy in patients over 75 years old with clinical atherosclerotic cardiovascular disease.
Lipid-Lowering Effects of Turmeric, Curcuminoids Examined
Findings of a recently published systematic review and meta-analysis revealed that turmeric and curcuminoids can significantly alter blood lipid levels in patients with metabolic diseases.
Addition of GLP-1 Agonists, SGLT2is May Benefit Patients on U-500 Insulin
Researchers conducted a retrospective chart review on patients from an endocrinology clinic who initiated a GLP-1 agonist and/or SGLT-2 inhibitor after receiving U-500 insulin for at least 3 months.
Does the Use of DPP4-is in Combination With Statins Increase Myopathy Risk?
FAERS database collects adverse events submitted by pharmaceutical companies, clinicians, and patients.
Direct-Acting Antiviral Therapy Reduced Risk for Incident T2D in Patients With Hepatitis C Infection
The study compared US administrative claims data of HCV patients with ≥12 weeks of dispensed DAA therapy (N = 17,848) to untreated HCV patients with follow-up data (N = 108,350).
Does Metformin Use Increase the Risk for Lactic Acidosis in T2D Patients?
Results demonstrated an incidence rate of 391/100,000 person years was calculated based on the 163 patients who were hospitalized with lactic acidosis during the follow-up period.
Some Rheumatoid Arthritis Drugs Beneficial in Diabetes
Research has shown that rheumatologic disease and diabetes frequently go hand-in-hand.
